News
Eisai debuts biliary tract cancer drug in Japan
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug
Digital
Tech & Trials: Can AI save us from drowning in data?
Data – it’s everywhere! Especially in clinical trials, where an average trial of about 2,000 patients can expect to produce 3,000,000 points of data.
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Market Access
Looking to history to prepare for America’s uncertain future
In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Returning... The 5th Operationalize Expanded Access Programs...
Welcome to, or welcome back to, the 5th Operationalize: Expanded Access Programs Summit 2025!
R&D
Partner Content
LEAP HR: Life Sciences Europe
Save the Date for LEAP HR: Life Sciences Europe! 18th-20th February, 2025, London, UK.
Category :
Views & Analysis
/
Digital and Social Media
